Global Program Head

Role: Global Program Head overseeing late-stage clinical development of radioligand imaging (RLI) agents for solid tumor staging, responsible for strategic leadership, program design, and execution to support regulatory approval and market access. Responsibilities: define and drive the program’s strategic vision, manage the entire lifecycle including design of Target Product Profiles and Development Plans, lead cross-functional teams, foster stakeholder relationships, and oversee external partnerships and co-development activities. Accountable for regulatory compliance, program milestones, and delivering enterprise value. Lead a global team, shape portfolio strategy, and influence decision-making across research, development, and commercial functions. Requirements: Board-certified radiologist or equivalent; significant experience in radioligand imaging development, particularly in late-stage programs, with expertise in regulatory strategy and stakeholder engagement. Preferred: experience managing global development teams, co-development partnerships, and navigating complex regulatory landscapes for imaging agents in oncology. High-value specifics: focus on radioligand agents for solid tumor staging, late-stage clinical development, regulatory strategy, and external partner management. Work setup: not specified; likely global and cross-functional leadership role.